Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117107) titled 'Study of Follicule X Hair Growth Serum for Hair Loss' on Sept. 7.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Other Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Supraceuticals Private Limited
Condition:
Health Condition 1: L650- Telogen effluvium
Intervention:
Intervention1: Follicule X hair serum: Participants will receive Follicule X Serum, a topical hair growth formulation containing Procapil, Redensyl, Anagain, Baicapil, Capilia Longa, Biotin, Copper Tripeptide-1 and caffeine. The study product wi...